SGLT2 inhibitor promotes ketogenesis to improve MASH by suppressing CD8+ T cell activation.
Liu W, You D, Lin J, Zou H, Zhang L, Luo S, Yuan Y, Wang Z, Qi J, Wang W, Ye X, Yang X, Deng Y, Teng F, Zheng X, Lin Y, Huang Z, Huang Y, Yang Z, Zhou X, Zhang Y, Chen R, Xu L, Li J, Yang W, Zhang H.
Liu W, et al. Among authors: lin j, lin y.
Cell Metab. 2024 Oct 1;36(10):2245-2261.e6. doi: 10.1016/j.cmet.2024.08.005. Epub 2024 Sep 6.
Cell Metab. 2024.
PMID: 39243758